InvestorsHub Logo
Followers 7
Posts 621
Boards Moderated 0
Alias Born 01/10/2018

Re: k9narc post# 50496

Monday, 03/01/2021 9:39:10 PM

Monday, March 01, 2021 9:39:10 PM

Post# of 64394
The value here is their IP. The nyloxin sales are just a bonus. If they can make 2 or 300k per year to offset some r&d costs, that's awesome.